Skip to main content
OpenTrials

Clinical trial condition

Hyperammonemia

Explore clinical trials studying Hyperammonemia. Study availability and eligibility vary by location and protocol.

20 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Hyperammonemia trial results

Recruiting

An Open-label Study to Investigate ECUR-506 in Male Babies Less Than 9 Months of Age With Neonatal Onset OTC Deficiency

NCT06255782

Conditions
Amino Acid Metabolism, Inborn Errors, Brain Diseases, Brain Diseases, Metabolic, +19 more
Locations
  • UCLA Mattel Children's Hospital Los Angeles, California, United States
  • Children's Hospital of Colorado, Anshutz Medical Campus Aurora, Colorado, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
View Trial Details
Recruiting

An Observational Study of Carbaglu® for the Treatment of MMA and PA in Adults and Pediatrics

NCT05040178

Conditions
Amino Acid Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +9 more
Locations
  • Children's National Hospital Washington D.C., District of Columbia, United States
  • University of South Florida Tampa, Florida, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Riley Children's Hospital Indianapolis, Indiana, United States
View Trial Details
Enrolling by Invitation

International Registry of Congenital Portosystemic Shunt (IRCPSS)

NCT06041906

Conditions
46, XX Disorders of Sex Development, Adrenogenital Syndrome, Brain Diseases, +45 more
Locations
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Lurie Children's Hospital Chicago, Illinois, United States
  • Royal Children's Hospital Melbourne Parkville, Victoria, Australia
  • Universitary Clinics Saint-Luc, UCL Brussels, Belgium
View all 26 locations
View Trial Details
Completed

To Evaluate the Safety of Long-term Use of HPN-100 in the Management of Urea Cycle Disorders (UCDs)

NCT01257737

Conditions
Amino Acid Metabolism, Inborn Errors, Brain Diseases, Brain Diseases, Metabolic, +13 more
Locations
  • UCLA Pediatrics/Genetics Los Angeles, California, United States
  • Stanford University School of Medicine Palo Alto, California, United States
  • Denver Children's Hospital Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 16 locations
View Trial Details
Completed

Study of the Safety and Tolerability of HPN-100 Compared to Sodium Phenylbutyrate in Children With Urea Cycle Disorders

NCT00947544

Conditions
Amino Acid Metabolism, Inborn Errors, Brain Diseases, Brain Diseases, Metabolic, +13 more
Locations
  • UCLA Los Angeles, California, United States
  • The George Washington DC Children's National Medical Center Washington D.C., District of Columbia, United States
  • Mount Sinai School of Medicine New York, United States
  • University of Pittsburgh Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

Study of the Safety, Pharmacokinetics and Efficacy of HPN-100, in Pediatric Subjects With Urea Cycle Disorders (UCDs)

NCT01347073

Conditions
Amino Acid Metabolism, Inborn Errors, Brain Diseases, Brain Diseases, Metabolic, +13 more
Locations
  • UCLA Pediatrics/Genetics Los Angeles, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Maine Medical Center Portland, Maine, United States
  • University of Minnesota Minneapolis, Minnesota, United States
View Trial Details

Related conditions